SCHEMBL52281

SCHEMBL52281

O=C(NCc1ccc(F)cc1)c1nc2n(c(=O)c1O)C1CCC2(N(Cc2ccccc2)C(=O)O)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.43
CYP2C9 P11712 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
THRB P10828 1/20 0.39
ERCC1 P07992 1/20 0.39
FEN1 P39748 1/20 0.39
ERCC4 Q92889 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CALCA P06881 1/20 0.38
OPRL1 P41146 2/20 0.38
KCNE1 P15382 1/20 0.37
CCR1 P32246 1/20 0.37
KCNQ1 P51787 1/20 0.37
TSHR P16473 1/20 0.37
TP53 P04637 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL52492 0.87 KCNH2 (0.46) KCNH2CYP2C9SMN1; SMN2L3MBTL1THRB
SCHEMBL10143686 0.82 CYP2C9 (0.55) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL51956 0.82 KCNH2 (0.45) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL62969 0.81 KCNH2 (0.47) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL2634091 0.81 KCNH2 (0.45) KCNH2CYP2C9SMN1; SMN2L3MBTL1THRB
SCHEMBL63394 0.80 KCNH2 (0.40) KCNH2CYP2C9SMN1; SMN2L3MBTL1THRB
SCHEMBL13255864 0.80 CYP2C9 (0.54) KCNH2CYP2C9SMN1; SMN2L3MBTL1THRB
SCHEMBL64102 0.78 KCNH2 (0.46) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52461 0.78 KCNH2 (0.49) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL63098 0.77 KCNH2 (0.47) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280981-B1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-04-23 EP disclosed
EP-2280981-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-02-09 EP disclosed